Together for improved health care and less animal testing

VitalTissue gives human residual tissues that become available after surgery a new purpose as valuable material for scientific research. This way VitalTissue contributes to the health of the citizens of the Netherlands. VitalTissue has no profit motive.

Our goal? Making human residual tissues accessible for scientific research through a network of participating hospitals, thereby accelerating medical innovations, speeding up development of better medicine and reducing the dependence on animal testing.

VitalTissue collaborates with Isala Hospital Zwolle.

VitalTissue contracted the following research institutions:

  • Academisch Centrum Tandheelkunde Amsterdam (ACTA),
  • Amsterdam UMC (AMC and VUMC locations),
  • Burns Research Lab – Vereniging Samenwerkende Brandwondencentra Nederland (VSBN),
  • Chiron On-Chip Biotechnologies B.V.,
  • Danone Research & Innovation,
  • Utrecht University of Applied Sciences (HU),
  • Mimetas B.V.,
  • Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek (TNO),
  • National Institute for Public Health and the Environment (RIVM),
  • University of Groningen (RuG),
  • Technische Universiteit Eindhoven (TU/e)
  • University Medical Center Utrecht (UMCU),
  • VU Amsterdam.
  • Wageningen Universiteit en Research (WUR).

VitalTissue is a division of:

Partners:

New campaign

VitalTissue takes residual tissue further

Starting June 2026, we are working on expanding our network of hospitals and medical professionals who provide residual tissue, as well as researchers who use this vital residual tissue for their groundbreaking research. To support this, we have created a new brochure and several social media ads featuring some of our stakeholders sharing their experiences with VitalTissue. We would like to thank them sincerely for their contribution. Curious to learn more? Visit our campaign page.

VitalTissue. This is how it works

Often, not all tissue that is removed in surgery is needed for diagnostics and/or follow-up research. This residual tissue is usually destroyed. That is a pity, because human residual tissue offers great opportunities for scientific research to improve and accelerate drug development. VitalTissue makes this fresh tissue accessible to researchers in The Netherlands for existing and the development of new experimental models that better match human biology. As a consequence progression in medical research will be accelerated and dependence on animal testing will be reduced.

News

Interested?

VitalTissue
[email protected]
Jan van Krimpenweg 17
2031 CG Haarlem